ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 33 filers reported holding ACER THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,786 | -10.6% | 53,035 | 0.0% | 0.00% | – |
| Q2 2023 | $48,973 | +17.6% | 53,035 | -3.4% | 0.00% | – |
| Q1 2023 | $41,661 | -84.9% | 54,925 | -50.0% | 0.00% | – |
| Q4 2022 | $275,724 | +884.7% | 109,850 | +443.1% | 0.00% | – |
| Q3 2022 | $28,000 | -6.7% | 20,225 | -13.8% | 0.00% | – |
| Q2 2022 | $30,000 | -59.5% | 23,465 | -8.2% | 0.00% | – |
| Q1 2022 | $74,000 | +29.8% | 25,565 | +2.4% | 0.00% | – |
| Q4 2021 | $57,000 | -10.9% | 24,965 | 0.0% | 0.00% | – |
| Q3 2021 | $64,000 | -9.9% | 24,965 | 0.0% | 0.00% | – |
| Q2 2021 | $71,000 | +91.9% | 24,965 | +94.3% | 0.00% | – |
| Q3 2020 | $37,000 | -37.3% | 12,849 | -25.6% | 0.00% | – |
| Q2 2020 | $59,000 | -78.3% | 17,259 | -87.4% | 0.00% | – |
| Q1 2020 | $272,000 | -39.1% | 136,735 | +22.5% | 0.00% | – |
| Q4 2019 | $447,000 | -6.9% | 111,579 | -25.8% | 0.00% | – |
| Q3 2019 | $480,000 | +22.1% | 150,466 | +49.4% | 0.00% | – |
| Q2 2019 | $393,000 | – | 100,736 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 250,518 | $722,000 | 0.59% |
| Nantahala Capital Management | 990,655 | $2,853,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 82,421 | $237,000 | 0.04% |
| FEDERATED HERMES, INC. | 117,673 | $339,000 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 179 | $516,000 | 0.00% |
| Horan Securities, Inc. | 24 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 200 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 3 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 29 | $0 | 0.00% |
| NORTHERN TRUST CORP | 31,083 | $90,000 | 0.00% |